Results 81 to 90 of about 25,080,468 (342)
Pediatric Blood &Cancer, EarlyView.ABSTRACT A second allogeneic (allo‐)hematopoietic stem cell transplantation (HSCT2) is a potential curative option for pediatric patients with acute lymphoblastic leukemia (ALL) following relapse after first allogeneic transplantation (HSCT1), but its efficacy is limited by high relapse rates and transplant‐related toxicity in highly pretreated ...
Ava Momm +10 more
wiley +1 more source
Los Angeles Labor Negotiations Study [PDF]
, 2006 [Excerpt] Sjoberg Evashenk Consulting and Cornell University have completed a study of the City of Los Angeles’ labor negotiation policies, processes and practices, under contract with the City Controller’s Office.
Cornell University, School of Industrial and Labor Relations +1 more
core +1 more source
Pediatric Blood &Cancer, EarlyView.Abstract Background A routine baseline echocardiogram is often obtained prior to anthracycline administration in children with cancer. The utility of baseline echocardiogram is unclear in patients with standard risk B‐cell acute lymphoblastic leukemia (SR B‐ALL) as their anthracycline cumulative dose is low.
Ziyad Alrajhi +4 more
wiley +1 more source
Jazan Rainfall’s Seasonal Shift in Saudi Arabia: Evidence of a Changing Regional Climate
AtmosphereIn recent years, rainfall in the Jazan region of southwest Saudi Arabia has significantly increased, setting new records for monthly and daily rainfall in 2024 and leading to natural disasters.
M. Nazrul Islam +4 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Although most malignant germ cell tumors (GCTs) are highly curable with cisplatin‐based therapy, options for patients with multiply relapsed/refractory disease remain limited. For this population, we report the first pediatric use of gemcitabine, docetaxel, melphalan, and carboplatin (GemDMC) as part of sequential cycles of high‐dose ...
Maria Frost +10 more
wiley +1 more source
Paraneoplastic Lupus Nephritis in a Child With Neuroblastoma Recurrence
Pediatric Blood &Cancer, EarlyView.
Gabriele Mortari +9 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background/Objectives Outcomes for pediatric relapsed/refractory (R/R) acute myeloid leukemia (AML) remain dismal. CPX‐351, a liposomal formulation of cytarabine and daunorubicin, may have less off‐target toxicities than traditional chemotherapies and has shown improved outcomes for adults with newly diagnosed therapy‐related AML.
Jonathan D. Bender +17 more
wiley +1 more source
Case Reports in Clinical Practice -Congress
Case Reports in Clinical Practice, 2019 of ...
case reports
doaj
Productivity Growth in Service Industries: A Canadian Success Story [PDF]
The Canadian service sector has performed well in recent years in terms of labour and multifactor productivity growth, both in absolute terms and relative to the United States, offsetting much of the poorer performance of the manufacturing sector ...
Andrew Sharpe +2 more
core
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background L‐asparaginase is a critical component in treatment protocols for pediatric acute lymphoblastic leukemia. Acute pancreatitis reactions can necessitate delays and, in some cases, discontinuation of L‐asparaginase, which compromises outcomes.
Edward J. Raack +39 more
wiley +1 more source